The role of MPV/albumin ratio in determining disease severity in acute cholangitis in the emergency medicine

Year 2022, Volume: 5 Issue: 5, 1378 - 1384, 25.09.2022

Enes Seyda Şahiner , Aziz Surel , Osman İnan , Nuray Yılmaz Çakmak , Emin Altıparmak , İhsan Ateş

https://doi.org/10.32322/jhsm.1146602

Cited By: 1

Abstract

Background: We aimed to examine the relationship of mean platelet volume (MPV) / albumin ratio (MAR) with disease and disease severity in patients with acute cholangitis.
Material and Method: Cases older than 18 years of age, who applied to the emergency department and were diagnosed with acute cholangitis after detailed evaluation were included in the study.Tokyo 2018 criteria are used to determine the severity of acute cholangitis.
Result: There was a positive correlation between MAR levels and Tokyo severity,and increased MAR levels were determined as an independent predictor for each risk group.The cut-off value of the MAR level in predicting moderate risk compared to the mild risk group was found to be >20.9% with 73.3% sensitivity and 70.6% specificity (AUC±SE=0.785±0.03; +PV= 51.3%, -PV= 86.2%; p< 0.001). The cut-off value of the MAR level in predicting severe risk compared to the moderate risk group was found to be >23.2% with 77.2% sensitivity and 59.1% specificity (AUC±SE=0.744±0.03; +PV= 64.5%, -PV= 72.9%; p<0.001).Mean MAR levels were found to be higher in patients admitted to the ICU compared to those who were not admitted (25.2±6.0 vs 21.3±4.6; p<0.001) and increased MAR levels were a potential risk factor for mortality (HR= 1.09; p<0.001).
Conclusion: We found that the MAR level is a very good marker in determining the severity of acute cholangitis.

Keywords

Abdominal pain, acute cholangitis, jaundice, mean platelet volume, Tokyo 2018

References

• Liau K-H, Teh C, Serrablo A. Management of acute cholecystitis and acute cholangitis in emergency setting. Open Med 2014; 9: 357-69.
• Flemma RJ, Osterhout S, Shingleton WW. Bacteriologic studies of biliary tract infection. Ann Surg 1967; 166: 563.
• Lee, J.G., Diagnosis and management of acute cholangitis. Nature reviews Gastroenterol Hepatol 2009; 6: 533-41.
• An Z, Braseth AL, Sahar N. Acute cholangitis: Causes, diagnosis, and management. Gastroenterol Clin 2021; 50: 403-14.
• Gupta M, Sachdev A. Acute cholangitis-an overview of diagnosis and medical Management. J Med Coll Chandigarh 2016; 6: 1-8.
• Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepato‐Biliary‐Pancreatic Sci 2018; 25: 17-30.
• Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm 2019; 2019: 9213074.
• Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001; 96: 776-81.
• Polińska B, Matowicka-Karna J, Kemona H. Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (colitis ulcerosa). Folia Histochem Cytobiol 2011; 49: 119-24.
• Yüksel O, Helvaci K, Başar O, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets 2009; 20: 277-81.
• Becchi C, Al Malyan M, Fabbri LP, Marsili M, Boddi V, Boncinelli S. Mean platelet volume trend in sepsis: is it a useful parameter? Minerva Aanestesiologica 2006; 72: 749-56.
• Gao, Y., Yi Li, Xuezhong Yu, et al. The impact of various platelet indices as prognostic markers of septic shock. PLoS One 2014; 9: e103761.
• Seker A, Incebiyik A, Kucuk A, et al. Mean platelet volume in patients with acute and chronic cholecystitis. Acta Med Mediter 2013; 29: 515-9.
• Bozkurt S, Köse A, Erdogan S, et al. MPV and other inflammatory markers in diagnosing acute appendicitis. J Pak Med Assoc 2015; 65: 637-41.
• Gencay I, Büyükkocak U, Ates G, Çaglayan O, Mean platelet volume and platelet distribution width as mortality predictors in ıntensive care unit. J Health Sci Med 2020; 3: 51–55.
• Behera MK, Mishra D, Sahu MK, et al. C-reactive protein/albumin and ferritin as predictive markers for severity and mortality in patients with acute pancreatitis, Gastroenterology Rev 2022; 17: 1.
• Chen YH, Wang L, Feng SY, et al. The relationship between C-reactive protein/albumin ratio and disease activity in patients with inflammatory bowel disease. Gastroenterol Res Pract 2020; 2020: 3467419
• Liu Z, Shi H, Chen L. Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis. BMC Cancer 2019; 19: 1-9.
• Kinoshita A, Onoda H, Imai N, et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol 2015; 22: 803-10.
• Mocellin MC, Silva JAP, Camargo CQ, et al. Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients. Lipids 2013; 48: 879-88.
• Liu X, Sun X, Liu J, et al. Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Translational Oncology 2015; 8: 339-45.
• Xu HJ, Ma Y, Deng F, Ju WB, Sun XY, Wang H. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis. OncoTargets and Therapy 2017; 10: 3059.
• Silangcruz K, Nishimura Y, Czech T, Kimura N, Yess J. Procalcitonin to Predict severity of acute cholangitis and need for urgent biliary decompression: systematic scoping review. J Clin Med 2022; 11: 1155.